Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

Share Price is delayed by 15 minutes
Get Live Data
660.00    -19.00 (-2.80%)
Bid:
657.00
Ask:
660.00
Spread: 3.00 (0.457%)
Market Cap: £1.21b
VLX Live PriceLast checked at - London Stock Exchange

Intraday Volex Share Chart

Interim Management Statement

27 Jul 2010 07:00

RNS Number : 9455P
Volex Group PLC
27 July 2010
 



 

 

For immediate release 27 July 2010

VOLEX GROUP plc

 

Interim Management Statement for the 16 weeks ended 27 July 2010

 

Volex Group plc ('Volex' or the 'Group'), the global electrical and electronic cable assemblies group, today releases its first Interim Management Statement for the FY2011 financial year, covering the 16 weeks ended 27 July 2010.

 

Trading momentum established during the last financial year (FY2010) has continued in the first quarter of FY2011, with revenue growth accelerating significantly beyond growth rates reported last year.

 

Highlights for the first quarter of FY2011 (three months to 4 July 2010) are as follows:

·; Revenue of £75m, up 23% on Q4 FY2010 (19% on constant currency basis) and up 39% on Q1 FY2010 (33% on constant currency basis)

·; Gross margin of 19.7%, 0.2pts down on previous quarter and 0.5pts ahead of same quarter last year

·; Operating profit(i) of £4.0m, up 5% on Q4 FY2010 and up 33% on Q1 FY2010

·; Net debt of £5.0m at end of Q1 FY2011, a £2.6m (34%) improvement since the end of last financial year and £12.8m (72%) better than at the end of Q1 FY2010

 (i) before share based payments charge

 

All four of our sectors (Telecom/Datacom, Healthcare, Consumer and Industrial) have experienced double digit percentage growth rates quarter-on-quarter with revenue growth in the Consumer and Telecom/Datacom sectors particularly strong. While all sectors have benefited from the improving economic environment, incremental revenue from new products and organic Sales initiatives has also been a significant feature.

 

The Group maintains its focus on increasing the proportion of value added Volex content in its products and on improving manufacturing efficiencies. We are also targeting strategic product development and new account opportunities in order to capitalise on improved trading conditions and to generate a platform for sustained growth and margin improvement.

 

 

Consumer sector revenue of £48m in Q1 has increased 19% quarter-on-quarter and 50% compared to Q1 of FY2010, both in constant currency terms, representing an acceleration of the quarterly sequential revenue growth reported last year. Our customers in this sector, particularly in Asia, have seen increased consumer confidence, as the global economic recovery gathers pace, and have increased manufacturing volumes accordingly. In addition to these macro-economic factors, we have been successful in increasing sales from our new environmentally-friendly products (including halogen-free and Phthalate-free) and have made progress in further developing our strategic partnerships with our global consumer electronics customers.

 

Revenue in the Telecom/Datacom sector of £16m in the first quarter represented an improvement of 26% over Q4 FY2010 and a 5% deterioration compared to the first quarter of FY2010 (again both in constant currency terms). The sector has enjoyed strong sequential growth driven by increased sales to Chinese telecoms OEM customers and improved, though still challenging, market conditions in India.

 

Trading in the Healthcare and Industrial sectors continued on the upward path established last financial year, with Q1 FY2011 revenue of £6m in Healthcare and £5m in Industrial, up 8% and 10% on Q4 FY2010, respectively, at constant currency.

 

As with revenue, the Group continued its trend of sequential improvement in quarterly profits. Operating profit for the quarter of £4.0m represented a significant improvement of 33% over Q1 FY2010 and 5% in quarter-on-quarter terms.

 

The Group also made good progress in its strategic objective of repaying debt, reducing net debt at the end of the first quarter of FY2011 to £5.0m from £7.6m at the end of FY2010, despite the increase in trading activity. This represents a 72% improvement when compared to net debt at the end of Q1 FY2010 of £17.8m.

 

Although pleased with performance in the first quarter, the Board recognises that Volex is at an early stage in its return to growth and remains aware of the significant work ahead. However, the Board is comfortable that the Group will meet or exceed the previous full year guidance on the trading outlook for the twelve months to 3 April 2011.

 

 

 

- END -

 

 

 

Volex Group plc

 

Ray Walsh, Group Chief Executive +44 20 3370 8833

Andrew Cherry, Group Finance Director +44 20 3370 8833

 

 

Buchanan Communications

 

Charles Ryland / Jeremy Garcia +44 20 7466 5000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSSESFIMFSSESW
Date   Source Headline
26th May 20263:00 pmRNSNotice of Results
15th May 20267:45 amRNSHolding(s) in Company
11th May 20267:00 amRNSHolding(s) in Company
30th Apr 20263:07 pmRNSHolding(s) in Company
22nd Apr 20267:00 amRNSCapital Markets Event
7th Apr 20267:00 amRNSLaunch of £40 million Share Buyback Programme
7th Apr 20267:00 amRNSUpdate on Move to the Main Market
26th Mar 20265:30 pmRNSHolding(s) in Company
25th Mar 20267:00 amRNSTrading update and Notice of Capital Markets Event
20th Mar 20262:00 pmRNSDirector/PDMR Shareholding
10th Feb 20267:45 amRNSHolding(s) in Company
2nd Feb 20264:45 pmRNSDirector/PDMR Shareholding
30th Jan 20264:30 pmRNSDirector/PDMR Shareholding
21st Jan 20267:00 amRNSTrading Update
12th Jan 20265:30 pmRNSDirector/PDMR Shareholding
8th Jan 20262:00 pmRNSDirector/PDMR Shareholding
5th Jan 20263:00 pmRNSIssue of Equity and Total Voting Rights
15th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 20255:55 pmRNSDirector/PDMR Shareholding
4th Dec 202511:30 amRNSScrip Reference Price
12th Nov 20257:00 amRNSAppointment of Non-Executive Chair and CEO
12th Nov 20257:00 amRNSHalf-year Report
20th Oct 20257:00 amRNSNotice of Results
16th Oct 20257:00 amRNSHalf Year Trading Update
29th Sep 20251:25 pmRNSHolding(s) in Company
18th Sep 20257:00 amRNSHolding(s) in Company
15th Sep 202511:30 amRNSDirector/PDMR Shareholding
15th Sep 202510:15 amRNSHolding(s) in Company
5th Sep 20259:00 amRNSDirector/PDMR Shareholding
1st Sep 20251:00 pmRNSIssue of Equity and Total Voting Rights
7th Aug 20254:35 pmRNSResult of AGM
7th Aug 202512:30 pmRNSScrip Reference Price
7th Aug 20257:00 amRNSAGM Statement
4th Aug 20252:00 pmRNSHolding(s) in Company
7th Jul 20254:35 pmRNSPDMR / PCA Shareholding
4th Jul 202511:00 amRNSNotice of AGM and Publication of Annual Report
26th Jun 20257:00 amRNSPreliminary Group Results FY2025
2nd Jun 20257:00 amRNSNotice of Results and Investor Presentation
16th Apr 20252:00 pmRNSDirector/PDMR Shareholding
16th Apr 20251:00 pmRNSDirector/PDMR Shareholding
10th Apr 20256:00 pmRNSDirector/PDMR Shareholding
7th Apr 20257:00 amRNSFull Year Trading Update
19th Mar 20253:30 pmRNSDirector/PDMR Shareholding
13th Mar 20255:45 pmRNSHolding(s) in Company
27th Jan 20257:00 amRNSChange of Adviser
27th Jan 20257:00 amRNSTrading Update
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
3rd Jan 20257:00 amRNSDeferred Consideration for Acquisition
19th Dec 20247:00 amRNSForm 8.3 - Volex PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.